Cyclopamine, Hedgehog and psoriasis

Dermatology

Volumn 209, Issue 2, 2004, Pages 81-83

  Kuenzli, Stéphane ^a,b   Sorg, Olivier ^a   Saurat, Jean Hilaire ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; CYCLOPAMINE; IMMUNOSUPPRESSIVE AGENT; SONIC HEDGEHOG PROTEIN; STEROID; TAZAROTENE; UNCLASSIFIED DRUG;

ACNE; ANTINEOPLASTIC ACTIVITY; BASAL CELL CARCINOMA; CYCLOPIA; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; HUMAN; NONHUMAN; PATHOGENESIS; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; HUMANS; PROSPECTIVE STUDIES; PSORIASIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VERATRUM ALKALOIDS;

EID: 4444321799     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079588     Document Type: Editorial

References (14)

1. Taş S, Avci O: Rapid clearance of psoriatic skin lesions induced by topical cyclopamine: A preliminary proof of concept study. Dermatology 2004;209:126-131.
2. Binns W, Shupe JL, Keeler RF, James LF: Chronologic evaluation of teratogenicity in sheep fed Veratrum californicum. J Am Vet Med Assoc 1965;147:839-842.
3. Keeler RF, Binns W: Chemical compounds of Veratrum californicum related to congenital ovine cyclopian malformations: Extraction of active material. Proc Soc Exp Biol Med 1964;116:123-127.
4. Cooper MK, Porter JA, Young KE, Beachy PA: Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 1998;280:1603-1607.
5. Incardona JP, Gaffield W, Kapur RP, Roelink H: The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 1998;125:3553-3562.
6. Chen JK, Taipale J, Cooper MK, Beachy PA: Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002;16:2743-2748.
7. Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP, Beachy PA: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000;406:1005-1009.
8. Frentz G, Olsen JH: Malignant tumours and psoriasis: A follow-up study. Br J Dermatol 1999;140:237-242.
9. Duvic M, Helekar B, Schulz C, Cho M, DiSepio D, Hager C, DiMao D, Hazarika P, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman SM, Chandraratna RA, Robinson NA, Deucher A, Eckert RL, Nagpal S: Expression of a retinoid-inducible tumor suppressor, tazarotene-inducible gene 3, is decreased in psoriasis and skin cancer. Clin Cancer Res 2000;6:3249-3259.
10. Duvic M, Ni X, Talpur R, Herne K, Schulz C, Sui D, Ward S, Joseph A, Hazarika P: Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol 2003;121:902-909.
11. Kanda S, Mochizuki Y, Suematsu T, Miyata Y, Nomata K, Kanetake H: Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. J Biol Chem 2003;278:8244-8249.
12. Kuenzli S, Saurat JH: Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 2003;149:229-236.
13. Mann RK, Beachy PA: Cholesterol modification of proteins. Biochim Biophys Acta 2000;1529:188-202.
14. Spinella-Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Courtois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman-Roman S: Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 2001;114:2085-2094.